Daiwa Securities Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Daiwa Securities Group’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-485	Closed	-$19K	–	1362
2023 Q2	$19K	Hold	485	–	–	﹤0.01%	1107
2023 Q1	$12K	Hold	485	–	–	﹤0.01%	1102
2022 Q4	$10K	Buy	485 +51	+12%	+$1.09K	﹤0.01%	1117
2022 Q3	$8K	Hold	434	–	–	﹤0.01%	1142
2022 Q2	$4K	Buy	434 +78	+22%	+$979	﹤0.01%	1191
2022 Q1	$6K	Hold	356	–	–	﹤0.01%	1168
2021 Q4	$6K	Hold	356	–	–	﹤0.01%	1187
2021 Q3	$6K	Buy	356 +188	+112%	+$2.05K	﹤0.01%	1173
2021 Q2	$1K	Hold	168	–	–	﹤0.01%	1242
2021 Q1	$1K	Hold	168	–	–	﹤0.01%	1253
2020 Q4	$1K	Buy	+168	New	+$1.07K	﹤0.01%	1235

Daiwa Securities Group's ISEE Position: Q3 2023 in Review

Daiwa Securities Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 485 shares — an estimated $19K sold.

Daiwa Securities Group first reported a position in ISEE in Q4 2020 and held it in 11 quarters. The position peaked at $19K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Daiwa Securities Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Daiwa Securities Group sold 485 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $19K.
Daiwa Securities Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
Daiwa Securities Group's IVERIC bio, Inc. Common Stock position peaked at $19K in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Daiwa Securities Group's 13F filing for Q3 2023, filed 1 Nov 2023.